In this Aug. 28, 2006 file photo, a doctor holds a vial of the human papillomavirus (HPV) vaccine Gardasil in his Chicago office. A national estimate suggests that nearly half of U.S. men have mostly silent infections caused by the sexually-transmitted human papilloma virus, and that 1 in 4 has strains linked with several cancers. The study was released Thursday, Jan. 19, 2017.
In this Aug. 28, 2006 file photo, a doctor holds a vial of the human papillomavirus (HPV) vaccine Gardasil in his Chicago office. A national estimate suggests that nearly half of U.S. men have mostly silent infections caused by the sexually-transmitted human papilloma virus, and that 1 in 4 has strains linked with several cancers. The study was released Thursday, Jan. 19, 2017. Charles Rex Arbogast AP
In this Aug. 28, 2006 file photo, a doctor holds a vial of the human papillomavirus (HPV) vaccine Gardasil in his Chicago office. A national estimate suggests that nearly half of U.S. men have mostly silent infections caused by the sexually-transmitted human papilloma virus, and that 1 in 4 has strains linked with several cancers. The study was released Thursday, Jan. 19, 2017. Charles Rex Arbogast AP

Alarming rise in oral HPV cases in men

November 06, 2017 03:43 PM